Movement Disorder Market By Disease Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Movement Disorder Market
Movement Disorder Market: By Disease Type (Tremor, Parkinson’s disease, Dyskinesia, Tics, Dysphonic, Ataxia, Restless legs syndrome, Huntington’s disease, and Other movement disorders) & By Region-Forecast (2016-2021)
Report Code : HCR 0321
Updated Date: 23 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Movement Disorder Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Movement Disorder Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Rise new and advance treatment 
      4.1.3. Increasing prevalence of neurodegenerative diseases
      4.1.4. Patent expiry of many blockbuster drugs and emergence of new technologies
   4.2. Restraints
      4.2.1. Higher cost of research and development
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of Movement Disorder
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Movement Disorder Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Movement Disorder Market, By Disease Type
   6.1. Tremor
   6.2. Parkinson’s disease
   6.3. Dyskinesia
   6.4. Tics
   6.5. Dysphonic
   6.6. Ataxia
   6.7. Restless legs syndrome
   6.8. Huntington’s disease
   6.9. Others
7. Global Movement Disorder Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Movement Disorder – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Abbott Laboratories,Inc
   9.2. Baxter International, Inc
   9.3. Cardinal Health
   9.4. Boston Scientific Corporation
   9.5. Forest Laboratories
   9.6. Hospira, Inc
   9.7. F. Hoffmann-La Roche AG
   9.8. Medtronic, Inc
   9.9. Merck Serono
   9.10. Mylan Pharmaceuticals
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Movement disorders are neurological diseases and syndromes affecting the ability to generate and control movement. This disorder mainly affects brain, spinal cord and nerves throughout the body giving rise to cerebrovascular diseases, degenerative diseases of adult life etc. Globally, recent development of efficient and advance technology rise new and advance treatment, increasing prevalence of neurodegenerative diseases, patent expiry of many blockbuster drugs and emergence of new technologies are the prime growth drivers of movement disorder market. In addition, Increase in adoption of Movement Disorder in emerging economies such as China, India and others, will create new opportunities for global movement disorder market. However, higher cost of the research and development is the key restraints for global Musculoskeletal Diseases market.
Movement Disorder Market

Geographically North America dominated global Movement Disorder market, and North America is projected to have fastest growth, owing to high prevalence of the disorder, technological advancements and high awareness among the patient population. Europe was observed to be the second largest market and one of the leading research destinations for neurological disease diagnosis and treatment. Asia-Pacific and Rest of the World were observed to be the most potential markets for movement disorders diagnosis and treatment market.

This report identifies the global pharmaceutical contract manufacturing market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global pharmaceutical contract manufacturing market.

This report segments global Movement Disorder market on the basis of disease type and regional market as follows:
  • Movement Disorder Market, By Disease Type: Tremor, Parkinson’s disease, Dyskinesia, Tics, Dysphonic, Ataxia, Restless legs syndrome, Huntington’s disease and Other movement disorders
  • This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico

This report identifies all the major companies operating in the Movement Disorder market. Some of the major companies’ profiles in detail are as follows:
  • Abbott Laboratories,Inc
  • Baxter International, Inc
  • Cardinal Health
  • Boston Scientific Corporation
  • Forest Laboratories W.L
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports